Modification and Validation of a Laboratory Method for Determination of L-Asparaginase Activity in Patient Blood Serum

A. I. Osipiantz(Ministry of Health of the Russian Federation), Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), A. I. Karachunsky(Ministry of Health of the Russian Federation), О. М. Тумутолова(National Research Mordovia State University), Екатерина Блинова(Sechenov University), A. B. Shikalov(Ministry of Health of the Russian Federation), Denis Shimanovsky(Sechenov University)
Pharmaceutical Chemistry Journal
May 1, 2023
10.1007/s11094-023-02882-5
Cited by 0

Related Papers

Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles
|International Journal of Molecular Sciences|2021|85
Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
|Cells|2019|19
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
|Life|2020|13